Brief: Eloxx Pharmaceuticals Inc Reports Q3 Loss Per Share Of $0.09
10/11/2022 22:53
Nov 10 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* ELOXX PHARMACEUTICALS INC Q3 LOSS PER SHARE $0.09
Source text for Eikon: ID:nGNX25W1Sk
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome